Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) shares dropped 10.1% on Friday after Canaccord Genuity Group lowered their price target on the stock from $40.00 to $34.00. Canaccord Genuity Group currently has a buy rating on the stock. Trupanion traded as low as $21.32 and last traded at $21.38. Approximately 502,239 shares were traded during mid-day trading, a decline of 24% from the average daily volume of 659,466 shares. The stock had previously closed at $23.78.
Other research analysts have also recently issued research reports about the stock. Evercore ISI dropped their price objective on shares of Trupanion from $35.00 to $31.00 and set an “outperform” rating for the company in a research report on Tuesday, February 20th. Piper Sandler dropped their target price on Trupanion from $28.00 to $22.00 and set a “neutral” rating for the company in a research report on Friday. Finally, Stifel Nicolaus upped their price target on Trupanion from $25.00 to $28.00 and gave the company a “hold” rating in a research note on Friday, February 16th. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $32.33.
Get Our Latest Research Report on TRUP
Institutional Inflows and Outflows
Trupanion Trading Down 16.5 %
The company has a debt-to-equity ratio of 0.42, a current ratio of 1.63 and a quick ratio of 1.63. The business’s 50-day moving average price is $25.61 and its two-hundred day moving average price is $26.71. The company has a market capitalization of $833.50 million, a P/E ratio of -31.02 and a beta of 1.76.
Trupanion (NASDAQ:TRUP – Get Free Report) last posted its earnings results on Thursday, May 2nd. The financial services provider reported ($0.16) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.02. Trupanion had a negative return on equity of 9.10% and a negative net margin of 2.31%. The firm had revenue of $306.12 million for the quarter, compared to analyst estimates of $300.51 million. During the same period in the previous year, the company posted ($0.60) earnings per share. The company’s revenue for the quarter was up 19.4% on a year-over-year basis. As a group, analysts forecast that Trupanion, Inc. will post -0.43 EPS for the current fiscal year.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also
- Five stocks we like better than Trupanion
- Using the MarketBeat Dividend Yield Calculator
- MarketBeat Week in Review – 4/29 – 5/3
- How to Capture the Benefits of Dividend Increases
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What is the Australian Securities Exchange (ASX)
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.